Literature DB >> 11176943

A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.

J Pelletier1, L Suchet, T Witjas, M Habib, C R Guttmann, G Salamon, O Lyon-Caen, A A Chérif.   

Abstract

OBJECTIVES: To determine if callosal atrophy and interhemispheric dysfunction can be detected in the early stages of relapsing-remitting multiple sclerosis (MS) and to evaluate their progression in relation to the disability and evolution of lesions seen on magnetic resonance imaging during a 5-year period.
METHODS: We compared 30 patients who had clinically definite early-onset replasing-remitting MS and mild disability with control subjects. Regional and segmental callosal size and extent of white matter abnormalities on magnetic resonance imaging, as well as performance on tasks exploring interhemispheric transfer of motor, auditory, and sensory information were assessed. Patients with MS were evaluated at baseline and after 5 years. Physical disability was determined at both times using the Expanded Disability Status Scale score.
RESULTS: Patients with MS were seen with significant callosal atrophy and functional impairment of interhemispheric transfer at baseline that worsened during the 5-year study. A significant correlation was found between the magnitude of disability and the severity of morphological and functional callosal involvement at baseline. This association persisted at year 5. Baseline clinical characteristics such as age and prestudy relapse rate were unrelated to callosal size or interhemispheric performance. However, the number of baseline T2-weighted lesions was correlated with callosal involvement and this relation persisted at year 5.
CONCLUSION: Patients who had relapsing-remitting MS in the early stages of the disease and mild disability had significant callosal involvement that progressed over time. The relationship between disability, T2-weighted lesions load, and degree of morphological and functional callosal impairment confirm the potential value of using callosal dysfunction as a surrogate marker of disease progression in MS.

Entities:  

Mesh:

Year:  2001        PMID: 11176943     DOI: 10.1001/archneur.58.1.105

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  42 in total

1.  Diffusion tensor group tractography of the corpus callosum in clinically isolated syndrome.

Authors:  F Lin; C Yu; Y Liu; K Li; H Lei
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-21       Impact factor: 3.825

2.  Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development.

Authors:  Juha Martola; Leszek Stawiarz; Sten Fredrikson; Jan Hillert; Jakob Bergström; Olof Flodmark; Maria Kristoffersen Wiberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-21       Impact factor: 10.154

3.  Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy.

Authors:  Stephanie C Manson; Jacqueline Palace; Joseph A Frank; Paul M Matthews
Journal:  Exp Brain Res       Date:  2006-06-21       Impact factor: 1.972

4.  Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter.

Authors:  H Vrenken; S A R B Rombouts; P J W Pouwels; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

5.  Relationship between intelligence and the size and composition of the corpus callosum.

Authors:  Amanda D Hutchinson; J L Mathias; B L Jacobson; L Ruzic; A N Bond; Marie T Banich
Journal:  Exp Brain Res       Date:  2008-10-24       Impact factor: 1.972

Review 6.  [Corpus callosum. Landmark of the origin of cerebral diseases].

Authors:  E Hattingen; M Nichtweiss; S Blasel; F E Zanella; S Weidauer
Journal:  Radiologe       Date:  2010-02       Impact factor: 0.635

7.  Global and regional annual brain volume loss rates in physiological aging.

Authors:  Sven Schippling; Ann-Christin Ostwaldt; Per Suppa; Lothar Spies; Praveena Manogaran; Carola Gocke; Hans-Jürgen Huppertz; Roland Opfer
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

8.  Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis.

Authors:  Eric C Klawiter; Antonia Ceccarelli; Ashish Arora; Jonathan Jackson; Sonya Bakshi; Gloria Kim; Jennifer Miller; Shahamat Tauhid; Christian von Gizycki; Rohit Bakshi; Mohit Neema
Journal:  J Neuroimaging       Date:  2014-05-09       Impact factor: 2.486

9.  Investigating the role of the corpus callosum in regulating motor overflow in multiple sclerosis.

Authors:  Anne-Marie Ternes; Jerome J Maller; Joanne Fielding; Patricia Addamo; Owen White; Nellie Georgiou-Karistianis
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

10.  Structural brain abnormalities in juvenile myoclonic epilepsy patients: volumetry and voxel-based morphometry.

Authors:  Woo Suk Tae; Seung Bong Hong; Eun Yun Joo; Sun Jung Han; Jae-Wook Cho; Dae Won Seo; Jong-Min Lee; In Young Kim; Hong Sik Byun; Sun I Kim
Journal:  Korean J Radiol       Date:  2006 Jul-Sep       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.